Crossmark

Investigation of commercially available recombinant and conventional β-glucuronidases to evaluate the hydrolysis efficiencies against O-glucuronides and N-glucuronides in urinary drug screening

Crossref DOI link: https://doi.org/10.1007/s11419-025-00715-6

Published Online: 2025-03-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Namera, Akira

Saito, Takeshi

Nagao, Masataka
License Information

Text and Data Mining valid from 2025-03-05

Version of Record valid from 2025-03-05
More Information

Article History

Received: 26 December 2024

Accepted: 3 February 2025

First Online: 5 March 2025

Declarations

:

: The authors declare no conflicts of interest. The author Akira Namera is one of the Chief-in-Editors of Forensic Toxicology and was not involved in the peer-review of this article.

: All the procedures performed in this study were in accordance with the ethics committee of Hiroshima University and the 1964 Helsinki Declaration and its later amendments.

Document is current

Any future updates will be listed below